METHODS OF TREATING CANCERS ASSOCIATED WITH IMMUNOSUPPRESSIVE B CELLS
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Nov 28, 2024
app pub date -
Aug 24, 2022
filing date -
Aug 24, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Described herein is a method of treating a cancer or tumor associated with CD19 positive, CD38 positive, CD20 negative immunosuppressive B cells in an individual comprising administering to the individual a bispecific antibody that binds CD19 and CD38, thereby treating the cancer or tumor associated with CD19 positive, CD38 positive, CD20 negative immunosuppressive B cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully